© 2020 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
Supply Chain
Shining a Light on Supply Chain Visibility
March 19, 2018
Steve Cottrell assesses the risks of lapses in pharma's supply chain visibility and outlines what can be done to minimize them
Going to the Edge
December 12, 2016
Pharmaceutical Executive
How a Manufacturing Excellence program can deliver competitive advantage to a fast-changing global product mix-at lower cost, and with an unexpected workforce dividend to boot.
Steady Hands: AmerisourceBergen's Peyton Howell
August 15, 2016
Pharmaceutical Executive
Pharm Exec sits down with AmerisourceBergen supply chain leader Peyton Howell to discuss the latest trends in pharmaceutical distribution, including company efforts to boost efficiency, reliability, and enhance its groundbreaking partnership with Walgreens Boots Alliance.
Closing the Gaps in Drug Chain of Custody
April 28, 2016
Pharmaceutical Executive
Limitations of the Drug Supply Chain Security Act for pharma-and three strategies to fix them.
Supply Chain Integration or Bust… or Both
February 12, 2016
The recent formation of three mega supply-chain purchasing groups (Walgreen’s-AllianceBoots-AmerisourceBergen-Rite-Aid, McKesson-Celesio, CVS-Cardinal) denotes a shift in the balance of power between wholesalers, chains, generic pharmaceutical companies and branded pharma companies.
Pharma dot-gov: A New Business Model
February 05, 2016
Pharmaceutical Executive
An advocate of business system automation in the global pharma supply chain offers a six-pronged approach to adapting to the realities of a new age of mounting regulation and customer expectations.
CEO Snapshot: Steve Collis, Four Years Forward
December 08, 2015
Pharmaceutical Executive
A Pharm Exec conversation with AmerisourceBergen CEO Steve Collis
The Importance of Risk Intelligence in the Supply Chain
November 16, 2015
Leaders should understand the key themes of risk intelligence in the supply chain, writes Bronwyn Kunhardt.